GRP
HRTX icon

Global Retirement Partners’s Heron Therapeutics HRTX Stock Holding History

Global Retirement Partners’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.22K Hold
4,018
– – ﹤0.01% 3426
2025
Q3 		$5.06K Hold
4,018
– – ﹤0.01% 2972
2025
Q2 		$8.32K Buy
+4,018
New +$8.21K ﹤0.01% 2695
2024
Q4 		$6.15K Hold
4,018
– – ﹤0.01% 2593
2024
Q3 		$8K Hold
4,018
– – ﹤0.01% 2378
2024
Q2 		$14.1K Buy
4,018
+18
+0.5% +$55 ﹤0.01% 2159
2024
Q1 		$11.1K Hold
4,000
– – ﹤0.01% 2078
2023
Q4 		$8.8K Hold
4,000
– – ﹤0.01% 2118
2023
Q3 		$3.84K Hold
4,000
– – ﹤0.01% 2281
2023
Q2 		$4.64K Buy
4,000
+2,000
+100% +$3.57K ﹤0.01% 2233
2023
Q1 		$4.66K Buy
+2,000
New +$5.01K ﹤0.01% 2185

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Global Retirement Partners's HRTX Position: Q4 2025 in Review

Global Retirement Partners held its Heron Therapeutics (HRTX) position steady in Q4 2025 at 4,018 shares worth $5.22K. The position accounts for ﹤0.01% of the portfolio, ranked #3426.

Global Retirement Partners first reported a position in HRTX in Q1 2023 and has held it in 11 quarters since. The position peaked at $14.1K in Q2 2024. 170 funds tracked by Wall St. Rank hold HRTX as of Q4 2025.

  • Global Retirement Partners held 4,018 shares of Heron Therapeutics worth $5.22K as of Q4 2025.
  • Global Retirement Partners left its Heron Therapeutics share count unchanged in Q4 2025.
  • Heron Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3426 holding.
  • Global Retirement Partners first reported a position in Heron Therapeutics in Q1 2023 and has held it in 11 quarters since.
  • Global Retirement Partners's Heron Therapeutics position peaked at $14.1K in Q2 2024.
  • 170 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.